Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Titel:
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Auteur:
Raffi, Francois Rachlis, Anita Stellbrink, Hans-Jürgen Hardy, W David Torti, Carlo Orkin, Chloe Bloch, Mark Podzamczer, Daniel Pokrovsky, Vadim Pulido, Federico Almond, Steve Margolis, David Brennan, Clare Min, Sherene